Cargando…
Transcriptomic Profiling Reveals Novel Candidate Genes and Signalling Programs in Breast Cancer Quiescence and Dormancy †
SIMPLE SUMMARY: Breast cancer can return many years after treatment of the primary tumour. This is caused by cells that have spread to other parts of the body and entered a non-dividing state called quiescence or dormancy that can last for decades. Dormant cancer cells are not sensitive to conventio...
Autores principales: | Quayle, Lewis A., Spicer, Amy, Ottewell, Penelope D., Holen, Ingunn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392441/ https://www.ncbi.nlm.nih.gov/pubmed/34439077 http://dx.doi.org/10.3390/cancers13163922 |
Ejemplares similares
-
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention
por: Quayle, Lewis A., et al.
Publicado: (2018) -
The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015) -
The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells
por: Brown, Hannah K, et al.
Publicado: (2011) -
IL-1 drives breast cancer growth and bone metastasis in vivo
por: Holen, Ingunn, et al.
Publicado: (2016) -
The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo
por: Allocca, Gloria, et al.
Publicado: (2019)